Ignite Creation Date:
2024-05-06 @ 9:44 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03051672
Status:
TERMINATED
Last Update Posted:
2021-04-27
First Post:
2017-02-08
Brief Title:
Phase II PEMBROLIZUMAB PALLIATIVE RADIOTHERAPY IN BC
Sponsor:
Organization:
Dana-Farber Cancer Institute